Clinical Trials Logo

Clinical Trial Summary

Impairment in physical function is a significant problem for survivors of critical illness. There is a growing urgency to develop a core set of outcome measures, which can be adopted in clinical and research practice to evaluate efficacy in response to interventions such as rehabilitation.

Phase 1: Development of a new outcome measure. This study aims to examine the development of a single outcome measure which may be able to be utilised across the continuum of recovery of critical illness in the evaluation of physical function. The study will involve examination of two common physical function measures - the Physical Function in intensive care test scored (PFIT-s) and De Morton Mobility Index (DEMMI) and the development of a new measure based on rasch principles which may be able to capture physical functioning changes in individuals with critical illness. Aims: (1) To determine the clinical utility of two physical function measures (DEMMI and PFIT-s) when used in isolation across the hospital admission; and (2) To transform the (15-item) DEMMI and (4-item) PFIT-s into a single measure to evaluate function in intensive care survivors using Rasch analytical principles.

Phase 2: Measurement properties of the PACIFIC physical function outcome measure in an independent validation sample.


Clinical Trial Description

Consecutive eligible patients will be recruited into the study.

Phase 1: Two outcome measures - PFIT-s and DEMMI will be performed within 24 hour period. Order of testing will be randomised to minimise testing bias. Time-points of assessment are: awakening, ICU discharge and hospital discharge. Weekly measures will also be performed if required in ICU and/or ward settings for up to a maximum of 30 days in each setting. The measurement properties of the individual tools PFIT-s and DEMMI will be examined (e.g. validity, responsiveness).

Phase 2: Based on the findings in Phase 1 a new single outcome measure will be developed. In the second phase examination of the measurement properties of the tool will be undertaken including (reliability, validity, responsiveness). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02911896
Study type Observational
Source University of Melbourne
Contact
Status Completed
Phase N/A
Start date August 2015
Completion date August 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Recruiting NCT03810768 - Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Completed NCT03717831 - Muscle Dysfunction in Critical Illness
Recruiting NCT05211661 - Diaphragm Atrophy and Dysfunction in Mechanical Ventilation
Completed NCT05282576 - Effect of Neurophysiological Facilitation Techniques in Intensive Care Patients N/A
Completed NCT03124342 - Vanderbilt ICU Recovery Program Pilot Trial N/A
Completed NCT03819959 - Metabolomics Study on Intensive Care Acquired Muscle Weakness in Polytrauma
Active, not recruiting NCT02685215 - Prognostic Factors , Morbidity and Mortality in Patients With Neuromuscular Disorders Admitted in ICU
Completed NCT01372176 - Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial Phase 4
Completed NCT03619915 - Correlation Between Spirometry and Functional Independence in Adult Post-ICU Patients
Completed NCT01364714 - Biomechanical Properties in Intensive Care Unit (ICU) Survivors 12-month After Discharge N/A
Completed NCT02358512 - Intermittent Versus Continuous Feeding in ICU Patients Phase 2
Completed NCT03714399 - Muscle Recovery Following Aortic Surgery Induced ICUAW.
Active, not recruiting NCT03936920 - Intra and Inter Reliability and Validity of the Turkish Version of Ottowa Sitting Scale in Intensive Care Unit Survivors
Terminated NCT01633593 - Treatment of Delirium in the Elderly With Donepezil: a Double-blind, Randomized, Placebo-controlled Clinical Trial Phase 4
Completed NCT03547687 - Neurosciences-Intensive Care Unit Electrical Stimulation N/A
Recruiting NCT03753412 - Recovery From ICUAW Following Severe Respiratory and Cardiac Failure